Volume | 396,836 |
|
|||||
News | - | ||||||
Day High | 49.00 | Low High |
|||||
Day Low | 47.32 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Janux Therapeutics Inc | JANX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
48.80 | 47.32 | 49.00 | 48.85 | 47.96 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9,496 | 396,836 | US$ 48.07 | US$ 19,075,588 | - | 5.65 - 58.6936 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
09:21:33 | 35 | US$ 49.50 | USD |
Janux Therapeutics (JANX) Options Flow Summary
Janux Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.52B | 51.66M | - | 8.08M | -58.29M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Janux Therapeutics News
Date | Time | Source | News Article |
---|---|---|---|
09/3/2024 | 08:47 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
09/3/2024 | 08:23 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
09/3/2024 | 08:11 | Edgar (US Regulatory) | Form 8-K - Current report |
09/3/2024 | 08:01 | Business Wire | Janux Therapeutics Reports Fourth Quarter and Full Year 2023.. |
01/3/2024 | 09:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
01/3/2024 | 09:11 | Edgar (US Regulatory) | Form 8-K - Current report |
29/2/2024 | 17:22 | Business Wire | Janux Therapeutics Announces Pricing of $296.5 Million.. |
29/2/2024 | 13:55 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
29/2/2024 | 09:15 | Edgar (US Regulatory) | Form 8-K - Current report |
28/2/2024 | 13:50 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
28/2/2024 | 09:23 | Edgar (US Regulatory) | Form 8-K - Current report |
28/2/2024 | 09:00 | Business Wire | Janux Therapeutics Announces Proposed Public Offering of.. |
Historical JANX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 47.06 | 56.27 | 47.00 | 50.79 | 1,273,033 | 2.69 | 5.72% |
1 Month | 40.15 | 56.27 | 34.6425 | 45.06 | 771,276 | 9.60 | 23.91% |
3 Months | 9.60 | 58.6936 | 7.79 | 43.62 | 940,197 | 40.15 | 418.23% |
6 Months | 7.74 | 58.6936 | 5.65 | 39.13 | 500,519 | 42.01 | 542.76% |
1 Year | 15.18 | 58.6936 | 5.65 | 34.16 | 306,633 | 34.57 | 227.73% |
3 Years | 34.00 | 58.6936 | 5.65 | 28.32 | 182,828 | 15.75 | 46.32% |
5 Years | 34.00 | 58.6936 | 5.65 | 28.32 | 182,828 | 15.75 | 46.32% |